Xie, S. C., Metcalfe, R. D., Mizutani, H., Puhalovich, T., Hanssen, E., Morton, C. J., Du, Y., Dogovski, C., Huang, S.-C., Ciavarri, J., Hales, P., Griffin, R. J., Cohen, L. H., Chuang, B.-C., Wittlin, S., Deni, I., Yeo, T., Ward, K. E., Barry, D. C., … Tilley, L. (2021). Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences, 118(39). https://doi.org/10.1073/pnas.2107213118
Subjects:
Ubiquitin-Proteasome Proteolytic Pathway
(OpenAlex Topic)
Malaria
(OpenAlex Topic)
Efficacy and Safety of Antiretroviral Therapy for HIV
(OpenAlex Topic)
Boron Compounds
(MeSH)
Malaria, Falciparum
(MeSH)
Plasmodium falciparum
(MeSH)
Proteasome Inhibitors
(MeSH)
Publication Type:
Article
Unique ID:
10.1073/pnas.2107213118
PMID:
Publication Date:
Data Source:
PubMed